Xiaoxiao Xu

503 total citations
21 papers, 314 citations indexed

About

Xiaoxiao Xu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Xiaoxiao Xu has authored 21 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Xiaoxiao Xu's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Platelet Disorders and Treatments (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Xiaoxiao Xu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Platelet Disorders and Treatments (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Xiaoxiao Xu collaborates with scholars based in China. Xiaoxiao Xu's co-authors include Jiawei Wang, Shan Zhu, Zhaowu Tao, Yanru Wu, Chang Yang, Yao Luo, Beining Yang, Wei Dong, Yumei Zhang and Hualing Sun and has published in prestigious journals such as International Journal of Cancer, Journal of Cellular Physiology and Bone.

In The Last Decade

Xiaoxiao Xu

19 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxiao Xu China 11 176 96 44 42 37 21 314
Kristell Wanherdrick France 7 171 1.0× 61 0.6× 58 1.3× 37 0.9× 44 1.2× 8 275
Jae Ho Lee South Korea 10 187 1.1× 71 0.7× 98 2.2× 65 1.5× 25 0.7× 20 343
Takuya Kakuki Japan 12 164 0.9× 66 0.7× 40 0.9× 27 0.6× 40 1.1× 30 347
Fuyun Ji China 14 226 1.3× 88 0.9× 50 1.1× 31 0.7× 21 0.6× 19 329
Funian Lu China 13 197 1.1× 76 0.8× 117 2.7× 52 1.2× 21 0.6× 19 359
Bowen Liu China 12 196 1.1× 82 0.9× 41 0.9× 32 0.8× 30 0.8× 27 329
Ivan Kanchev Czechia 10 103 0.6× 35 0.4× 62 1.4× 52 1.2× 34 0.9× 14 326
Nives Giebeler Germany 6 146 0.8× 75 0.8× 83 1.9× 28 0.7× 37 1.0× 6 297
Zhe Xing China 9 183 1.0× 89 0.9× 35 0.8× 68 1.6× 15 0.4× 14 293
Filomena Napolitano Italy 12 118 0.7× 44 0.5× 63 1.4× 90 2.1× 11 0.3× 27 319

Countries citing papers authored by Xiaoxiao Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoxiao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiao Xu more than expected).

Fields of papers citing papers by Xiaoxiao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiao Xu. The network helps show where Xiaoxiao Xu may publish in the future.

Co-authorship network of co-authors of Xiaoxiao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiao Xu. A scholar is included among the top collaborators of Xiaoxiao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiao Xu. Xiaoxiao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaoxiao, Ming Tan, Xuan Liu, et al.. (2025). Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis. Frontiers in Pharmacology. 16. 1549214–1549214.
2.
Xu, Xiaoxiao, et al.. (2025). Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapy. Cancer Treatment Reviews. 140. 103012–103012.
3.
Yang, Beining, Yan Wang, Shuo Wang, et al.. (2024). Inhibition of fibulin‐3 ameliorates periodontal inflammation through reducing M1 macrophage polarization via EGFR/PI3K/AKT pathway. Journal of Periodontology. 96(5). 440–454. 3 indexed citations
4.
Gao, Tao, Bin Zhou, Xiaoxiao Xu, et al.. (2023). Fast green FCF prevents postoperative cognitive dysfunction via the downregulation of the P2X4 receptor in mice. International Immunopharmacology. 121. 110462–110462. 2 indexed citations
5.
Wu, Hang, et al.. (2023). P2X4 receptor modulates gut inflammation and favours microbial homeostasis in colitis. Clinical and Translational Medicine. 13(4). e1227–e1227. 4 indexed citations
6.
7.
Zhang, Yumei, Shunli Wang, Xiaoxiao Xu, et al.. (2022). mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis. Frontiers in Pharmacology. 13. 861938–861938. 8 indexed citations
8.
Xu, Xiaoxiao, Chang Yang, Xijie Yu, & Jiawei Wang. (2022). Fibulin-3 regulates the inhibitory effect of TNF-α on chondrocyte differentiation partially via the TGF-β/Smad3 signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(9). 119285–119285. 3 indexed citations
9.
Yu, Xijie, Xiaoxiao Xu, Wei Dong, et al.. (2022). DDIT3/CHOP mediates the inhibitory effect of ER stress on chondrocyte differentiation by AMPKα-SIRT1 pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(8). 119265–119265. 13 indexed citations
10.
Xu, Xiaoxiao, Tong Yu, & Zhenxing Wang. (2022). Discoidin Domain Receptor 2: A New Target in Cancer. Oncology Research and Treatment. 45(4). 205–215. 7 indexed citations
11.
Xu, Xiaoxiao, et al.. (2022). DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor‐infiltrating T cells through IL‐18. Cancer Science. 113(11). 3672–3685. 25 indexed citations
12.
Yang, Chang, Yao Luo, Wei Dong, et al.. (2022). USP7 Attenuates Endoplasmic Reticulum Stress and NF‐κB Signaling to Modulate Chondrocyte Proliferation, Apoptosis, and Inflammatory Response under Inflammation. Oxidative Medicine and Cellular Longevity. 2022(1). 1835900–1835900. 18 indexed citations
13.
Dong, Wei, Xiaoxiao Xu, Yao Luo, et al.. (2021). PTX3 promotes osteogenic differentiation by triggering HA/CD44/FAK/AKT positive feedback loop in an inflammatory environment. Bone. 154. 116231–116231. 19 indexed citations
14.
Wu, Hang, Xiaoxiao Xu, Xingwang Li, et al.. (2021). Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth. Frontiers in Pharmacology. 12. 717529–717529. 35 indexed citations
15.
Yang, Chang, Xiaoxiao Xu, Beining Yang, et al.. (2021). DDIT3/CHOP promotes autophagy in chondrocytes via SIRT1-AKT pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(9). 119074–119074. 30 indexed citations
16.
Yang, Zhen, Xiaoxiao Xu, & Cheng Song. (2020). Circular RNA La-Related Protein 4 Inhibits Non-Small Cell Lung Cancer Cell Proliferation While Promotes Apoptosis Through Sponging microRNA-21-5p. Cancer Biotherapy and Radiopharmaceuticals. 37(2). 111–118. 10 indexed citations
17.
Xu, Xiaoxiao, et al.. (2020). USP7 regulates the proliferation and differentiation of ATDC5 cells through the Sox9-PTHrP-PTH1R axis. Bone. 143. 115714–115714. 14 indexed citations
18.
Wang, Liangliang, et al.. (2019). Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor. Biomedicine & Pharmacotherapy. 120. 109533–109533. 11 indexed citations
19.
Zhou, Rui, Xiaoxiao Xu, Meizhen Liu, Xinmou Wu, & Rong Li. (2018). Immunophenotypes of Ductal Epithelial Cells in Advanced Pancreatic Ductal Adenocarcinoma. Digestion. 99(3). 247–251. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristell Wanherdrick Breakdown of academic impact, for papers by Jae Ho Lee Breakdown of academic impact, for papers by Takuya Kakuki Breakdown of academic impact, for papers by Fuyun Ji Breakdown of academic impact, for papers by Funian Lu Breakdown of academic impact, for papers by Bowen Liu Breakdown of academic impact, for papers by Ivan Kanchev Breakdown of academic impact, for papers by Nives Giebeler Breakdown of academic impact, for papers by Zhe Xing Breakdown of academic impact, for papers by Filomena Napolitano
Rankless by CCL
2026